Literature DB >> 18845766

A feeder-free and efficient production of functional neutrophils from human embryonic stem cells.

Koichi Saeki1, Kumiko Saeki, Masako Nakahara, Satoko Matsuyama, Naoko Nakamura, Yoshiko Yogiashi, Asako Yoneda, Makoto Koyanagi, Yasushi Kondo, Akira Yuo.   

Abstract

A novel, feeder-free hematopoietic differentiation protocol was established for highly efficient production of neutrophils from human embryonic stem cells (hESCs). For the induction of differentiation, spheres were generated in the presence of serum and cytokine cocktail and subjected to attachment culture on gelatin-coated plates. After approximately 2 weeks, a sac-like structure filled with abundant round cells emerged at the center of flattened spheres. After cutting off this sac-like structure, round cells actively proliferated, either floating in the supernatant or associated weakly with the adherent cells. Almost all of these round cells were CD45-positive hematopoietic cells with myeloid phagocytic markers (CD33 and CD11b), and approximately 30%-50% of the round cells were mature neutrophils, as judged from morphology, cytochemical characteristics (myeloperoxidase and neutrophil alkaline phosphatase), and neutrophil-specific cell surface markers (CD66b, CD16b, and GPI-80). In addition, hESC-derived neutrophils had chemotactic capacity in response to the bacterial chemotactic peptide formyl-methionyl-leucyl-phenylalanine and neutrophil-specific chemokine interleukin (IL)-8. Using "semipurified" neutrophils migrated to IL-8, both phagocytic and respiratory burst activities were demonstrated. Finally, it was shown that hESC-derived neutrophils had chemotactic activity in vivo in a murine air-pouch inflammatory model. The present results indicate successful induction of functional mature neutrophils from hESCs via highly efficient feeder-free differentiation culture system of human hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18845766     DOI: 10.1634/stemcells.2007-0980

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  26 in total

Review 1.  Vascular potential of human pluripotent stem cells.

Authors:  Ionela Iacobas; Archana Vats; Karen K Hirschi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-07       Impact factor: 8.311

Review 2.  Generation of mature hematopoietic cells from human pluripotent stem cells.

Authors:  Padma Priya Togarrati; Kran Suknuntha
Journal:  Int J Hematol       Date:  2012-05-31       Impact factor: 2.490

3.  Three-dimensional epithelial tissues generated from human embryonic stem cells.

Authors:  Kyle J Hewitt; Yulia Shamis; Mark W Carlson; Edith Aberdam; Daniel Aberdam; Jonathan A Garlick
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

4.  Functional neutrophils from human ES cells.

Authors:  Colin L Sweeney; Harry L Malech
Journal:  Blood       Date:  2009-06-25       Impact factor: 22.113

5.  Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells.

Authors:  Kyung-Dal Choi; Maxim Vodyanik; Igor I Slukvin
Journal:  Nat Protoc       Date:  2011-02-17       Impact factor: 13.491

6.  Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model.

Authors:  Dong Li; Hong Yang; Hong Nan; Peng Liu; Sulei Pang; Qian Zhao; Rotem Karni; Mark P Kamps; Yuanfu Xu; Jiaxi Zhou; Therese Wiedmer; Peter J Sims; Fei Wang
Journal:  Blood       Date:  2012-10-18       Impact factor: 22.113

Review 7.  Mesodermal and hematopoietic differentiation from ES and iPS cells.

Authors:  Tomoko Inoue-Yokoo; Kenzaburo Tani; Daisuke Sugiyama
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

8.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.

Authors:  Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney
Journal:  Blood       Date:  2014-06-16       Impact factor: 22.113

Review 9.  The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.

Authors:  Katja G Weinacht; Patrick M Brauer; Kerstin Felgentreff; Alex Devine; Andrew R Gennery; Silvia Giliani; Waleed Al-Herz; Axel Schambach; Juan Carlos Zúñiga-Pflücker; Luigi D Notarangelo
Journal:  Curr Opin Immunol       Date:  2012-07-25       Impact factor: 7.486

Review 10.  Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.

Authors:  Dan S Kaufman
Journal:  Blood       Date:  2009-08-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.